Investegate |XBiotech Inc. Announcements | XBiotech Inc.: XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy
XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy Appointments Include: Chair, Clay Johnston, M.D., Ph.D. as well as Members Greg Albers, M.D. and Brett Cucchiara, M.D. AUSTIN, Texas, Jan. 19, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today the first meeting of its Cerebrovascular Medical Advisory Board (CMAB). The CMAB is comprised of key opinion leaders who specialize in cerebrovascular diseases including ischemic stroke, which is the third leading cause of death and second leading cause of disability in the world. The CMAB...
Source: investegate.co.uk
